T2 Biosystems Presents Data on Rapid and Direct Hemostasis Monitoring at American Society of Hematology 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on T2Hemostasis, the first system capable of rapidly characterizing key coagulation, platelet and other hematologic factors directly from whole blood on a single, compact instrument. The data were presented by researchers from the University of Pennsylvania at the 54th Annual Meeting of the American Society for Hematology (ASH) in Atlanta, GA. The study demonstrated that T2MR technology can be applied through the T2Hemostasis assay to rapidly and accurately measure changes in hemostasis across a range of conditions, from impaired hemostasis to hypercoagulable states.